Patents by Inventor Kathryn Bell

Kathryn Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11607030
    Abstract: An accessory attachment assembly for a garment and a garment with an accessory attachment assembly are disclosed herein. In particular, the accessory attachment assembly includes a first base disposed on an exterior surface of the garment and a second base disposed on an interior of the garment in an at least partially aligned relation to one another. A strap extends from one end of the first base and is disposable between an at least partially open position and a closed position via cooperative first and second fastener defining a loop and allowing for the removable attachment of an accessory. A third fastener is attached to the second base allowing for the removable attachment of an additional accessory thereto.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: March 21, 2023
    Inventor: Kathryn A. Bell
  • Publication number: 20190139102
    Abstract: Systems and methods are provided for practicing Relational Fitness abilities. A relational fitness development and fundraising tool includes a server having a processor and a memory, a storage system in communication with the processor and storing challenge activity information, and a collaboration, reporting, and payment application stored in the memory and including a graphical user interface (GUI) module and a rule module. The processor executes the GUI and rule modules to selectively operate the application in a daily challenge mode, a training mode, a tournament mode, and a fundraising mode, where all of the operational modes involve user athletes completing relational fitness challenge activities in exchange for points and/or for fundraising dollars on behalf of a beneficiary. Other embodiments are also disclosed.
    Type: Application
    Filed: September 27, 2018
    Publication date: May 9, 2019
    Inventors: Stephen Huff, Andrew Bennetts, Tamara Williams, Kathryn Bell, Ned Nixon, Eric Epstein, James Rice, Donna Rice, Peter Girard, Heather Hooton, Madeline Tyo, Juli Dimos
  • Patent number: 9242987
    Abstract: The invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: January 26, 2016
    Assignee: Cellzome Limited
    Inventors: Nigel Ramsden, Richard John Harrison, Sally Oxenford, Kathryn Bell, Nelly Piton, Claudio Dagostin, Cyrille Broussard, Andrew Ratcliffe
  • Patent number: 9040545
    Abstract: The present invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: May 26, 2015
    Assignee: Cellzome Limited
    Inventors: Kathryn Bell, Nelly Piton, Claudio Dagostin, Cyrille Boussard, Andrew Ratcliffe, Nigel Ramsden
  • Patent number: 8883820
    Abstract: The invention relates to compounds of formula (I); wherein X and R1 to R5 have the meaning as cited in the description and the claims. Said compounds are useful as protein kinase inhibitors, especially inhibitors of Itk or PI3K, for the treatment or prophylaxis of immunological, inflammatory or allergic disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the production of and use as medicaments.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: November 11, 2014
    Assignee: Cellzome Ltd.
    Inventors: Francis Wilson, Nigel Ramsden, Kathryn Bell, Andrew Cansfield, Svenja Burckhardt, Jess Taylor, Mihiro Sunose, David Middlemiss
  • Patent number: 8865699
    Abstract: The invention relates to compounds of formula (I) wherein X, T1 and R1 to R3 have the meaning as cited in the description and the claims. Said compounds are useful as protein kinase inhibitors, especially inhibitors of PI3K, for the treatment or prophylaxis of immunological, inflammatory, autoimmune, or allergic disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the production of and use as medicaments.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: October 21, 2014
    Assignee: Cellzome Ltd.
    Inventors: Nigel Ramsden, Kathryn Bell, Andrew David Cansfield, Jess Taylor, Mihiro Sunose, David Middlemiss, Gitte Neubauer
  • Publication number: 20130190292
    Abstract: The present invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
    Type: Application
    Filed: August 12, 2011
    Publication date: July 25, 2013
    Applicant: CELLZOME LIMITED
    Inventors: Kathryn Bell, Nelly Piton, Claudio Dagostin, Cyrille Boussard, Andrew Ratcliffe, Nigel Ramsden
  • Patent number: 8367830
    Abstract: The present invention relates to immobilization compounds of formula (I), immobilization products and preparations thereof as well as methods and uses for the identification of phosphatidylinositol kinase interacting compounds or for the purification or identification of phosphatidylinositol kinase proteins.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: February 5, 2013
    Assignee: Cellzome AG
    Inventors: Kathryn Bell, Nigel Ramsden, Giovanna Bergamini Moore, Gitte Neubauer
  • Publication number: 20120252779
    Abstract: The invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
    Type: Application
    Filed: October 19, 2010
    Publication date: October 4, 2012
    Inventors: Nigel Ramsden, Richard John Harrison, Sally Oxenford, Kathryn Bell, Nelly Piton, Claudio Dagostin, Cyrille Boussard, Andrew Ratcliffe
  • Publication number: 20120135421
    Abstract: The present invention relates to immobilization compounds of formula (I), immobilization products and preparations thereof as well as methods and uses for the identification of phosphatidylinositol kinase interacting compounds or for the purification or identification of phosphatidylinositol kinase proteins.
    Type: Application
    Filed: May 14, 2010
    Publication date: May 31, 2012
    Applicant: Cellzome AG
    Inventors: Kathryn Bell, Nigel Ramsden, Giovanva Bergamini Moore, Gitte Neubauer
  • Publication number: 20110021497
    Abstract: The invention relates to compounds of formula (I) wherein X, T1 and R1 to R3 have the meaning as cited in the description and the claims. Said compounds are useful as protein kinase inhibitors, especially inhibitors of PI3K, for the treatment or prophylaxis of immunological, inflammatory, autoimmune, or allergic disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the production of and use as medicaments.
    Type: Application
    Filed: November 21, 2008
    Publication date: January 27, 2011
    Inventors: Nigel Ramsden, Kathryn Bell, Andrew David Cansfield, Jess Taylor, Mihiro Sunose, David Middlemiss, Gitte Neubauer
  • Publication number: 20100227800
    Abstract: The invention relates to compounds of formula (I); wherein X and R1 to R5 have the meaning as cited in the description and the claims. Said compounds are useful as protein kinase inhibitors, especially inhibitors of Itk or PI3K, for the treatment or prophylaxis of immunological, inflammatory or allergic disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the production of and use as medicaments.
    Type: Application
    Filed: August 30, 2007
    Publication date: September 9, 2010
    Applicant: CELLZOME LIMITED
    Inventors: Francis Wilson, Nigel Ramsden, Kathryn Bell, Andrew Cansfield, Svenja Burckhardt, Jess Taylor, Mihiro Sunose, David Middlemiss